Wijziging van de Geneesmiddelenwet in verband met technische verbeteringen en verhoging van het boetemaximum

This legislative proposal aims to update the Dutch Medicines Act by introducing technical improvements and increasing the maximum fines for violations. The goal is to ensure the law remains effective and up-to-date with current practices and challenges in the pharmaceutical sector. The changes will primarily affect pharmaceutical companies, regulatory bodies, and potentially consumers by ensuring better compliance and stronger enforcement mechanisms within the Dutch healthcare system.